Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease

Journal of Experimental Medicine

Volumn 210, Issue 7, 2013, Pages 1403-1418

  Falta, Michael T ^a   Pinilla, Clemencia ^b   Mack, Douglas G ^a   Tinega, Alex N ^a   Crawford, Frances ^c,d   Giulianotti, Marc ^b   Santos, Radleigh ^b   Clayton, Gina M ^c,d   Wang, Yuxiao ^e   Zhang, Xuewu ^e   Maier, Lisa A ^a,c   Marrack, Philippa ^c,d   Kappler, John W ^c,d   Fontenot, Andrew P ^a,c  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

^c DEPARTMENT OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BERYLLIUM; GLUTAMIC ACID; HLA DP ANTIGEN; HLA DP2 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLEXIN; PLEXIN A4; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; BERYLLIOSIS; CD4+ T LYMPHOCYTE; CHRONIC BERYLLIUM DISEASE; CHRONIC DISEASE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; BERYLLIOSIS; BERYLLIUM; BINDING SITES; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CHRONIC DISEASE; HLA-DP BETA-CHAINS; HUMANS; MICE; PEPTIDE LIBRARY; PEPTIDES; RECEPTORS, CELL SURFACE;

EID: 84880689464     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122426     Document Type: Article

References (46)

1. + T cells is dependent on a single amino acid residue of the MHC class II β-chain. J. Immunol. 175:7029-7037.
2. Boen, E., A.R. Crownover, M. McIlhaney, A.J. Korman, and J. Bill. 2000. Identification of T cell ligands in a library of peptides covalently attached to HLA-DR4. J. Immunol. 165:2040-2047.
3. Bowerman, N.A., M.T. Falta, D.G. Mack, J.W. Kappler, and A.P. Fontenot. 2011. Mutagenesis of beryllium-specific TCRs suggests an unusual binding topology for antigen recognition. J. Immunol. 187:3694-3703. http://dx.doi.org/10.4049/jimmunol.1101872
4. Crawford, F., H. Kozono, J. White, P. Marrack, and J. Kappler. 1998. Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. Immunity. 8:675-682. http://dx.doi.org/10.1016/S1074-7613(00)80572-5
5. + T cells in type 1 diabetes in the nonobese diabetic (NOD) mouse. Proc. Natl. Acad. Sci. USA. 108:16729-16734. http://dx.doi.org/10.1073/pnas.1113954108
6. Dai, S., G.A. Murphy, F. Crawford, D.G. Mack, M.T. Falta, P. Marrack, J.W. Kappler, and A.P. Fontenot. 2010. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc. Natl. Acad. Sci. USA. 107:7425-7430. http://dx.doi.org/10.1073/pnas.1001772107
7. Davis, M.M., J.J. Boniface, Z. Reich, D. Lyons, J. Hampl, B. Arden, and Y. Chien. 1998. Ligand recognition by α β T cell receptors. Annu. Rev. Immunol. 16:523-544. http://dx.doi.org/10.1146/annurev.immunol.16.1.523
8. Day, C.L., N.P. Seth, M. Lucas, H. Appel, L. Gauthier, G.M. Lauer, G.K. Robbins, Z.M. Szczepiorkowski, D.R. Casson, R.T. Chung, et al. 2003. Ex vivo analysis of human memory CD4 T cells specific for hepatitis C virus using MHC class II tetramers. J. Clin. Invest. 112:831-842.
9. Díaz, G., B. Cañas, J. Vazquez, C. Nombela, and J. Arroyo. 2005. Characterization of natural peptide ligands from HLA-DP2: new insights into HLA-DP peptide-binding motifs. Immunogenetics. 56:754-759. http://dx.doi.org/10.1007/s00251-004-0735-5
10. Fontenot, A.P., and L.A. Maier. 2005. Genetic susceptibility and immunemediated destruction in beryllium-induced disease. Trends Immunol. 26:543-549. http://dx.doi.org/10.1016/j.it.2005.08.004
11. Fontenot, A.P., M.T. Falta, B.M. Freed, L.S. Newman, and B.L. Kotzin. 1999. Identification of pathogenic T cells in patients with beryllium-induced lung disease. J. Immunol. 163:1019-1026.
12. + T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl. Acad. Sci. USA. 97:12717-12722. http://dx.doi.org/10.1073/pnas.220430797
13. + T cells in patients with chronic beryllium disease. J. Clin. Invest. 110:1473-1482.
14. + T cells in blood determines proliferative response. J. Clin. Invest. 115:2886-2893. http://dx.doi.org/10.1172/JCI24908
15. He, H., T. Yang, J.R. Terman, and X. Zhang. 2009. Crystal structure of the plexin A3 intracellular region reveals an autoinhibited conformation through active site sequestration. Proc. Natl. Acad. Sci. USA. 106:15610-15615. http://dx.doi.org/10.1073/pnas.0906923106
16. Hemmer, B., C. Pinilla, J. Appel, J. Pascal, R. Houghten, and R. Martin. 1998. The use of soluble synthetic peptide combinatorial libraries to determine antigen recognition of T cells. J. Pept. Res. 52:338-345. http://dx.doi.org/10.1111/j.1399-3011.1998.tb00658.x
17. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S.E. Straus, et al. 1999. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5:1375-1382. http://dx.doi.org/10.1038/70946
18. + T-cell memory. Nat. Med. 7:913-919. http://dx.doi.org/10.1038/90950
19. Huseby, E.S., F. Crawford, J. White, J. Kappler, and P. Marrack. 2003. Negative selection imparts peptide specificity to the mature T cell repertoire. Proc. Natl. Acad. Sci. USA. 100:11565-11570. http://dx.doi.org/10.1073/pnas.1934636100
20. Huseby, E.S., J. White, F. Crawford, T. Vass, D. Becker, C. Pinilla, P. Marrack, and J.W. Kappler. 2005. How the T cell repertoire becomes peptide and MHC specific. Cell. 122:247-260. http://dx.doi.org/10.1016/j.cell.2005.05.013
21. Illing, P.T., J.P. Vivian, N.L. Dudek, L. Kostenko, Z. Chen, M. Bharadwaj, J.J. Miles, L. Kjer-Nielsen, S. Gras, N.A. Williamson, et al. 2012. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 486:554-558.
22. Kreiss, K., M.M. Mroz, B. Zhen, J.W. Martyny, and L.S. Newman. 1993a. Epidemiology of beryllium sensitization and disease in nuclear workers. Am. Rev. Respir. Dis. 148:985-991. http://dx.doi.org/10.1164/ajrccm/148.4_Pt_1.985
23. Kreiss, K., S. Wasserman, M.M. Mroz, and L.S. Newman. 1993b. Beryllium disease screening in the ceramics industry. Blood lymphocyte test performance and exposure-disease relations. J. Occup. Med. 35:267-274.
24. 3. Am. J. Ind. Med. 30:16-25. http://dx.doi.org/10.1002/(SICI)1097-0274(199607)30:1<16::AID-AJIM3>3.0.CO;2-Q
25. Lombardi, G., C. Germain, J. Uren, M.T. Fiorillo, R.M. du Bois, W. Jones-Williams, C. Saltini, R. Sorrentino, and R. Lechler. 2001. HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease. J. Immunol. 166:3549-3555.
26. Marrack, P., and J.W. Kappler. 2012. Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases? Cold Spring Harb. Perspect. Med. 2:a007765. http://dx.doi.org/10.1101/cshperspect. a007765
27. Molberg, O., S.N. Mcadam, R. Körner, H. Quarsten, C. Kristiansen, L. Madsen, L. Fugger, H. Scott, O. Norén, P. Roepstorff, et al. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 4:713-717. http://dx.doi.org/10.1038/nm0698-713
28. Moon, J.J., H.H. Chu, J. Hataye, A.J. Pagán, M. Pepper, J.B. McLachlan, T. Zell, and M.K. Jenkins. 2009. Tracking epitope-specific T cells. Nat. Protoc. 4:565-581. http://dx.doi.org/10.1038/nprot.2009.9
29. Mroz, M.M., K. Kreiss, D.C. Lezotte, P.A. Campbell, and L.S. Newman. 1991. Reexamination of the blood lymphocyte transformation test in the diagnosis of chronic beryllium disease. J. Allergy Clin. Immunol. 88:54-60. http://dx.doi.org/10.1016/0091-6749(91)90300-D
30. Nepom, G.T. 2012. MHC class II tetramers. J. Immunol. 188:2477-2482. http://dx.doi.org/10.4049/jimmunol.1102398
31. Newman, L.S., K. Kreiss, T.E. King Jr., S. Seay, and P.A. Campbell. 1989. Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history. Am. Rev. Respir. Dis. 139:1479-1486. http://dx.doi.org/10.1164/ajrccm/139.6.1479
32. +) T cells proliferating in response to influenza A antigen. J. Clin. Invest. 104:R63-R67. http://dx.doi.org/10.1172/JCI8476
33. + T cell clones. J. Gen. Virol. 79:697-704.
34. + T cells in chronic beryllium disease. J. Immunol. 180:2704-2712.
35. Pinilla, C., J.R. Appel, P. Blanc, and R.A. Houghten. 1992. Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques. 13:901-905.
36. 12) sequences. Biochem. J. 301:847-853.
37. Pinilla, C., J.R. Appel, E. Borràs, and R.A. Houghten. 2003. Advances in the use of synthetic combinatorial chemistry: mixture-based libraries. Nat. Med. 9:118-122. http://dx.doi.org/10.1038/nm0103-118
38. Richeldi, L., R. Sorrentino, and C. Saltini. 1993. HLA-DPB1 glutamate 69: a genetic marker of beryllium disease. Science. 262:242-244. http://dx.doi.org/10.1126/science.8105536
39. Rossman, M.D., J.A. Kern, J.A. Elias, M.R. Cullen, P.E. Epstein, O.P. Preuss, T.N. Markham, and R.P. Daniele. 1988. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann. Intern. Med. 108:687-693. http://dx.doi.org/10.7326/0003-4819-108-5-687
40. Sidney, J., A. Steen, C. Moore, S. Ngo, J. Chung, B. Peters, and A. Sette. 2010. Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity. J. Immunol. 184:2492-2503. http://dx.doi.org/10.4049/jimmunol.0903655
41. Tinkle, S.S., L.A. Kittle, B.A. Schumacher, and L.S. Newman. 1997. Beryllium induces IL-2 and IFN-γ in berylliosis. J. Immunol. 158:518-526.
42. van der Merwe, P.A., and S.J. Davis. 2003. Molecular interactions mediating T cell antigen recognition. Annu. Rev. Immunol. 21:659-684. http://dx.doi.org/10.1146/annurev.immunol.21.120601.141036
43. + T-cell outcomes during specific immunotherapy. J. Allergy Clin. Immunol. 129:544-551. http://dx.doi.org/10.1016/j.jaci.2011.08.034
44. Wang, Y., H. He, N. Srivastava, S. Vikarunnessa, Y.B. Chen, J. Jiang, C.W. Cowan, and X. Zhang. 2012. Plexins are GTPase-activating proteins for Rap and are activated by induced dimerization. Sci. Signal. 5:ra6. http://dx.doi.org/10.1126/scisignal.2002636
45. Yin, L., F. Crawford, P. Marrack, J.W. Kappler, and S. Dai. 2012. T-cell receptor (TCR) interaction with peptides that mimic nickel offers insight into nickel contact allergy. Proc. Natl. Acad. Sci. USA. 109:18517-18522. http://dx.doi.org/10.1073/pnas.1215928109
46. Zhao, Y., B. Gran, C. Pinilla, S. Markovic-Plese, B. Hemmer, A. Tzou, L.W. Whitney, W.E. Biddison, R. Martin, and R. Simon. 2001. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J. Immunol. 167:2130-2141